Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
04/2000
04/13/2000WO2000020406A1 ANTIBACTERIAL AND ANTIFUNGAL FLAVANONES FROM $i(EYSENHARDTIA TEXANA)
04/13/2000WO2000020370A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/13/2000WO2000020000A1 Controlled release oral preparations of esculetin and its derivatives
04/13/2000WO2000019998A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
04/13/2000WO2000019990A2 Rar antagonists as male anti-fertility agents
04/13/2000WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
04/13/2000CA2346687A1 Use of rar antagonists or inverse agonists as male anit-fertility agents
04/13/2000CA2346333A1 Compositions and methods of inhibiting neoplastic diseases with compounds related to limocitrin and 5-desmethyl sinensetin
04/13/2000CA2346034A1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
04/12/2000EP0992500A2 Recovery of tocopherols
04/12/2000EP0992499A2 Recovery of tocopherols
04/12/2000EP0992239A1 Neuropeptide y receptor antagonist
04/12/2000EP0991636A1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
04/12/2000EP0794951B1 Processes and intermediates for preparing cis (+) 3-[4,6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline
04/12/2000EP0759917B1 Novel selective inhibitors of viral or bacterial neuraminidases
04/12/2000EP0655448B1 Benzopyran and benzoxazine derivatives
04/12/2000CN1250438A Naphthopyran derivatives, compositions and (CO) polymers matrices containing same
04/11/2000US6048988 Process for the production of α-tocopherol esters
04/11/2000US6048891 Administering mixtures with 6-hydroxy-2,7,8-trimethyl-chroman-2-propanoic acid for treatment of cardiovascular and kidney disorders
04/11/2000CA1340952C Chemiluminescent 1,2-dioxetane compounds
04/06/2000WO2000018755A1 Grey colouring photochromic fused pyrans
04/06/2000WO2000018754A1 Processes for the preparation of 4-substituted benzopyran derivatives
04/06/2000WO2000018738A1 Benzamide derivatives and their use as cytokine inhibitors
04/06/2000WO1999067192A3 PROCESS FOR THE SOLID PHASE SYNTHESIS OF ALDEHYDE, KETONE, OXIME, AMINE, HYDROXAMIC ACID AND α,β-UNSATURATED CARBOXYLIC ACID AND ALDEHYDE COMPOUNDS
04/06/2000WO1999037294A3 Mitochondria protecting agents for treating mitochondria associated diseases
04/06/2000CA2340454A1 Benzamide derivatives and their use as cytokine derivatives
04/05/2000EP0837844B1 Acrylamide derivatives as chromophoric photocrosslinking compound
04/05/2000CN1249306A Process for preparing benzodihydropyranol deriv.
04/05/2000CN1051089C Fruit polyphenol, process for production thereof, and use thereof
04/04/2000CA2204739C Macrocyclic lactone compounds and their production process
03/2000
03/30/2000WO2000017650A1 Energy transfer compositions comprising phycobiliproteins
03/30/2000WO2000017217A1 Process of obtaining genistin-rich isoflavone composition
03/30/2000WO2000017187A1 Processes for the preparation of isochromanones and intermediates for the preparation thereof
03/30/2000WO2000017186A1 Process for preparing 3-isochromanone
03/30/2000WO2000017185A1 Method for preparing vitamin e
03/30/2000WO2000017184A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/30/2000WO2000017183A1 3-(hydroxymethyl)chromen-4-ones and process for preparing
03/30/2000WO2000016772A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
03/30/2000DE19843672A1 Verfahren zur Herstellung von Chromanol-Derivaten A process for preparing chromanol derivatives
03/30/2000CA2345311A1 Hydroxyflavone derivatives as tau protein kinase 1 inhibitors
03/29/2000EP0989127A1 An antifungal lactone compound
03/29/2000EP0989126A1 Process for the production of chromanol derivatives
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988280A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
03/29/2000EP0894275A4 Photochromic naphthopyran compositions of improved fatigue resistance
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/28/2000US6043279 Compounds used for in vivo modulation of lipid metabolism, skin-related processes, malignant cell development, premalignant lesions, programmed cell death
03/28/2000US6043271 Method for the preparation of (±)-calanolide A and intermediates thereof
03/28/2000US6043269 Estrogen agonists
03/23/2000WO2000015631A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000WO2000015630A1 Polyalkoxylated naphthopyrans
03/23/2000WO2000015629A1 Polymerizable polyalkoxylated naphthopyrans
03/23/2000WO2000015628A1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them
03/23/2000WO2000015627A1 Process for the preparation of isoflavones
03/23/2000WO2000015618A1 Xanthan-ester and acridan substrates for horseradish peroxidase
03/23/2000WO2000015237A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015218A1 A new composition
03/23/2000WO2000015174A2 Bioflavonoid as blood glucose level lowering agent
03/23/2000CA2351548A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000CA2344054A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2342608A1 Bioflavonoid as blood glucose level lowering agent
03/23/2000CA2342600A1 Xanthan-ester and acridan substrates for horseradish peroxidase
03/23/2000CA2342341A1 A new composition
03/23/2000CA2342338A1 Naphthopyrans annelated in c5-c6, their preparation and compositions and (co) polymer matrices containing them
03/22/2000EP0987260A1 Photochromic spirofluorenopyrans
03/22/2000EP0987248A1 Amide derivatives and their therapeutic use
03/22/2000EP0987024A2 Immunosuppressive agents
03/22/2000EP0986551A1 Sulfonamide derivatives, their production and use
03/22/2000EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
03/22/2000EP0946440A4 2-adamantyl benzopyrans, the compositions and (co)polymer matrices containing them
03/22/2000EP0675713B1 Use of prodelphinidines for treating arthrosis
03/22/2000CN1248255A 3-heterocyclyl-substituted benzoyl derivatives
03/22/2000CN1050602C Process for preparation of substituted 4-hydroxycoumarins
03/21/2000US6040482 Produced in a single step by reacting an oxyalkylene oxide or oxyalkylester having from 3 to 12 carbon atoms, glycidol, or a glycidyl with an aminophenol without the use of a catalyst and at low temperatures; xanthene, coumarin dyes
03/21/2000US6040463 Sordarin derivatives
03/21/2000US6040308 Chroman derivatives
03/21/2000US6040126 Open chain a-carbonyl acetanilide yellow dye-forming coupler compound
03/21/2000CA2132745C Novel cardioprotective agents
03/16/2000WO2000014084A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents
03/16/2000CA2341353A1 Substituted dihydrobenzopyrans useful as antiarrhythmic agents
03/15/2000EP0984969A1 Fused dihydropyrans
03/15/2000EP0984952A1 A new salt
03/15/2000EP0984929A4 Naphthopyran derivatives, compositions and (co)polymers matrices containing same
03/15/2000EP0984929A1 Naphthopyran derivatives, compositions and (co)polymers matrices containing same
03/14/2000US6037477 Oxidation process of ethers
03/14/2000US6037377 Antiinflammatory agents and antiallergens
03/14/2000US6037365 Aminobenzamidinosuccinyl lactone derivatives useful as inhibitors of platelet aggregation
03/14/2000US6036890 Stable photochromic dye; sunglass lenses
03/14/2000CA2282147A1 Immunosuppresive agents
03/14/2000CA2281852A1 An antifungal lactone compound
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012086A1 Method of mitigating the adverse effects of interleukin-2
03/09/2000WO2000012084A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000WO2000012077A1 Potassium channel inhibitors and method
03/09/2000WO1999064408A8 Prodrugs of estrogen antagonist
03/09/2000CA2342222A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
03/09/2000CA2339947A1 Method of mitigating the adverse effects of interleukin-2
03/08/2000EP0983992A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983991A2 Compounds having selectivity for retinoid x receptors
03/08/2000EP0983259A1 Tocopherol esters and their cosmetic and pharmaceutical uses